Europe Intravenous Solutions Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Europe Intravenous Solutions Market Report is Segmented by Type (Total Parenteral Nutrition and Peripheral Parenteral Nutrition), Solution Composition (Saline, Carbohydrates, Vitamins and Minerals, and Other Solution Compositions), and Geography (Germany, The United Kingdom, France, Italy, Spain, and Rest of Europe). The Report Offers the Value (USD) for the Above Segments.

Europe Intravenous Solutions Market Size

Europe Intravenous Solutions Market Summary

Europe Intravenous Solutions Market Analysis

The Europe Intravenous Solutions Market size is estimated at USD 4.20 billion in 2025, and is expected to reach USD 5.47 billion by 2030, at a CAGR of 5.45% during the forecast period (2025-2030).

Factors such as the increasing prevalence of chronic diseases, such as gastrointestinal disorders, neurological diseases, and cancer, as well as advancements and innovations in products for patient convenience, are expected to drive market growth during the forecast period. For instance, according to the data updated by the Spanish Network of Cancer Registries (REDECAN) in January 2023, approximately 279,260 new cases of cancer occurred in Spain by the end of 2023, out of which 42,721 were new cases of colorectal cancer, 31,282 were cases of lung cancer, and 21,694 were cases of urinary bladder cancer. Therefore, the high incidence of cancer is predicted to increase the demand for intravenous solutions and is expected to further contribute to the market’s growth.

Additionally, the profound impact on the quality of life of patients afflicted with neurological disorders, alongside the escalating societal burden attributed to the aging demographic of the Western population. For instance, according to data published by University College London in October 2023, by 2040, England and Wales are projected to experience a significant increase in the prevalence of dementia, with 1.7 million individuals affected in England alone, exceeding previous estimates. NHS data released in November 2023 revealed a surge in dementia diagnoses, with 475,573 people identified in September 2023, representing a rise of over 52,000 from the previous year. This surge marked the highest dementia diagnosis rate in the past three years, highlighting an alarming trend. Thus, the increasing number of brain disorders is increasing the demand for intravenous solutions in the United Kindom, thereby contributing to the growth of the market studied.

Moreover, various initiatives taken by key players, such as product launches, investments, and partnerships to increase the footprint, are expected to boost the market's growth during the forecast period. For instance, in July 2023, Recce Pharmaceuticals Ltd reported positive results from a Phase I (R327-001) study of RECCE 327 (R327) as an intravenous (IV) infusion formulation in 80 healthy male subjects in Austria. When administered at doses much higher than the expected therapeutic window, R327 IV does not lead to safety or toxicity issues in healthy subjects.

Thus, the abovementioned factors, such as the high burden of chronic diseases and strategic initiatives, are expected to drive the market's growth during the forecast period. However, regulatory and quality requirements are expected to restrain the market's growth.

Europe Intravenous Solutions Industry Overview

The European intravenous solutions market is moderately competitive and consists of several major players. The market players adopted several strategies, such as the expansion of manufacturing and innovation in IV solutions, to stay competitive in the market. Some of the key players in the market are Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Grifols SA, and ICU Medical, Inc.

Europe Intravenous Solutions Market Leaders

  1. Baxter International Inc.

  2. B. Braun Melsungen AG

  3. Fresenius Kabi AG

  4. Grifols S.A.

  5. ICU Medical, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Europe Intravenous Solutions Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Europe Intravenous Solutions Market News

  • March 2024: Unilever Health & Wellbeing's expansion into the United Kingdom marked the debut of Liquid I.V. Liquid I.V.'s innovative electrolyte powder formula enhances hydration efficiency.
  • September 2023: ivWatch LLC announced the expansion of its technology offerings in the UK market via a multi-year, exclusive partnership agreement with Healthcare 21 Group (HC21), one of Europe's leading medical device distributors. ivWatch's patient monitoring technology helps protect patients from unpredictable IV complications by detecting early IV infiltration and extravasation.

Europe Intravenous Solutions Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Diseases, such as Gastrointestinal Disorder, Neurological Diseases, and Cancer
    • 4.2.2 Advancements and New Innovations in the Products for Patient Convenience
  • 4.3 Market Restraints
    • 4.3.1 Regulatory and Quality Requirements
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Type
    • 5.1.1 Total Parenteral Nutrition
    • 5.1.2 Peripheral Parenteral Nutrition
  • 5.2 By Solution Composition
    • 5.2.1 Saline
    • 5.2.2 Carbohydrates
    • 5.2.3 Vitamins and Minerals
    • 5.2.4 Other Solution Compositions
  • 5.3 By Geography
    • 5.3.1 Germany
    • 5.3.2 United Kingdom
    • 5.3.3 France
    • 5.3.4 Italy
    • 5.3.5 Spain
    • 5.3.6 Rest of Europe

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Baxter International Inc.
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Fresenius Kabi AG
    • 6.1.4 Grifols SA
    • 6.1.5 ICU Medical Inc.
    • 6.1.6 Sichuan Kelun Pharmaceutical Co. Ltd
    • 6.1.7 Terumo Corporation
    • 6.1.8 Otsuka Pharmaceutical Co. Ltd
    • 6.1.9 Amanta Healthcare Ltd
    • 6.1.10 Codan Argus AG
    • 6.1.11 Vifor Pharma Group
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Intravenous Solutions Industry Segmentation

As per the scope of the report, intravenous solutions are chemically prepared fluids administered in the body through the venous circulation to maintain or replace the level of lost body fluid. The European intravenous solutions market is segmented by type, solution composition, and geography. By type, the market is segmented into total parenteral nutrition and peripheral parenteral nutrition. By solution composition, the market is segmented into saline, carbohydrates, vitamins and minerals, and other solution compositions. By geography, the market is segmented into Germany, the United Kingdom, France, Italy, Spain, and Rest of Europe. The report offers the value (USD) for the above segments.

By Type Total Parenteral Nutrition
Peripheral Parenteral Nutrition
By Solution Composition Saline
Carbohydrates
Vitamins and Minerals
Other Solution Compositions
By Geography Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Need A Different Region or Segment?
Customize Now

Europe Intravenous Solutions Market Research FAQs

How big is the Europe Intravenous Solutions Market?

The Europe Intravenous Solutions Market size is expected to reach USD 4.20 billion in 2025 and grow at a CAGR of 5.45% to reach USD 5.47 billion by 2030.

What is the current Europe Intravenous Solutions Market size?

In 2025, the Europe Intravenous Solutions Market size is expected to reach USD 4.20 billion.

Who are the key players in Europe Intravenous Solutions Market?

Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Grifols S.A. and ICU Medical, Inc. are the major companies operating in the Europe Intravenous Solutions Market.

What years does this Europe Intravenous Solutions Market cover, and what was the market size in 2024?

In 2024, the Europe Intravenous Solutions Market size was estimated at USD 3.97 billion. The report covers the Europe Intravenous Solutions Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Intravenous Solutions Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Europe Intravenous Solutions Industry Report

Statistics for the 2025 Europe Intravenous Solutions market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Intravenous Solutions analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Europe Intravenous Solutions Market Report Snapshots

Compare market size and growth of Europe Intravenous Solutions Market with other markets in Healthcare Industry

Europe Intravenous Solutions Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)